State Street’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$128K Sell
103,100
-275,436
-73% -$342K ﹤0.01% 3934
2025
Q1
$462K Hold
378,536
﹤0.01% 3612
2024
Q4
$681K Buy
378,536
+63,500
+20% +$114K ﹤0.01% 3560
2024
Q3
$1.6M Buy
315,036
+256,029
+434% +$1.3M ﹤0.01% 3392
2024
Q2
$420K Buy
59,007
+37,307
+172% +$265K ﹤0.01% 3596
2024
Q1
$59.5K Hold
21,700
﹤0.01% 4128
2023
Q4
$58.2K Hold
21,700
﹤0.01% 4169
2023
Q3
$57.3K Buy
21,700
+1,900
+10% +$5.02K ﹤0.01% 4252
2023
Q2
$55.4K Hold
19,800
﹤0.01% 4393
2023
Q1
$57.4K Hold
19,800
﹤0.01% 4471
2022
Q4
$70.9K Hold
19,800
﹤0.01% 4466
2022
Q3
$64K Hold
19,800
﹤0.01% 4602
2022
Q2
$60K Sell
19,800
-75,270
-79% -$228K ﹤0.01% 4688
2022
Q1
$798K Buy
95,070
+1,991
+2% +$16.7K ﹤0.01% 3880
2021
Q4
$974K Buy
93,079
+6,978
+8% +$73K ﹤0.01% 3820
2021
Q3
$1.55M Buy
+86,101
New +$1.55M ﹤0.01% 3682